Skip to content
healthcare.dev

sildenafil CITRATE

NDC 59651-420, sildenafil CITRATE, powder, for suspension, from Aurobindo Pharma Limited.

Product NDC
59651-420
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214773
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-420 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SILDENAFIL CITRATE10 mg/mL

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
59651-420-11596510420111 BOTTLE in 1 CARTON (59651-420-11) / 112 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b60b4fdc-9b78-45e6-8438-8a30f83ed976
  • NADAC price for package 59651042011

    GET /v1/drugs/nadac/59651042011

Use it

Look up 59651-420 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-420 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-420. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.